½ÃÀ庸°í¼­
»óǰÄÚµå
1598769

´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå : Á¦Ç°, °ø±Þó, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Unit Dose Manufacturing Market by Product (Liquid Unit Dose, Solid Unit Dose), Sourcing (In-House, Outsourcing), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀº 2023³â 233¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 276¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 18.76% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 778¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ÜÀ§ ¿ë·® Á¦Á¶´Â »çÀü °è·®µÈ °³º° ¿ë·®ÀÇ ÀǾàǰÀ» Á¦Á¶ÇÏ´Â °ÍÀ¸·Î, ÀÇ·á ¹× Á¦¾à »ê¾÷¿¡¼­ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ƯÈ÷ º´¿ø°ú Àå±â¿ä¾ç½Ã¼³¿¡¼­ È¿°úÀûÀÎ Åõ¾à °ü¸®, ȯÀÚ ¾ÈÀü ¹× ó¹æµÈ Ä¡·á¹ý Áؼö¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±× Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¿ëµµ´Â ÀǾàǰ¿¡ ±¹ÇѵÇÁö ¾Ê°í, ¿µ¾çÁ¦ ¹× ÀϹÝÀǾàǰ±îÁö È®´ëµÇ°í ÀÖÀ¸¸ç, ´ÜÀ§ ¿ë·®À» Ȱ¿ëÇÏ¿© Á¤È®¼º°ú ¾ÈÀü¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡´Â º´¿ø, ÀçÅà ÀÇ·á, ¾à±¹ µîÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯ Áõ°¡, ÀǾàǰ À¯Åë ±ÔÁ¦ Áؼö, Åõ¾à ¿À·ù °¨¼Ò ÃßÁø µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀçÅà ÀÇ·á ¼­ºñ½ºÀÇ Áõ°¡¿Í ÀÚµ¿ ´ÜÀ§ ¿ë·® Æ÷Àå ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå¿¡ ÀáÀçÀûÀÎ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½º¸¶Æ® Æ÷Àå°ú ÀÚµ¿ Á¶Á¦ ½Ã½ºÅÛÀÇ ±â¼ú Çõ½ÅÀº ÅõÀÚÇÒ ¸¸ÇÑ °¡Ä¡°¡ ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ³ôÀº Ãʱ⠵µÀÔ ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö°¡ ¿ä±¸µÇ´Â º¹ÀâÇÑ ±ÔÁ¦ »óȲ°ú °°Àº Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü ±â¼úÀ» ÅëÇÕÇÏ·Á¸é ¼÷·ÃµÈ ÀηÂÀÌ ÇÊ¿äÇѵ¥, Àü¹® ÀÇ·á ºÐ¾ßÀÇ Àη °ÝÂ÷¸¦ °í·ÁÇÒ ¶§ ÀÌ´Â ¾î·Á¿î °úÁ¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å°ú ¿¬±¸´Â ºñ¿ë È¿À²ÀûÀ̰í È¿À²ÀûÀÎ Æ÷Àå ¼Ö·ç¼Ç °³¹ß°ú ¾à¹° ¼øÀÀµµ ÃßÀû ¹× ¸ð´ÏÅ͸µÀ» °­È­ÇÏ´Â µðÁöÅÐ °Ç°­ ±â¼ú ÅëÇÕ¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­Çϸç, °¢ ¾÷üµéÀº ±â¼ú ¿ª·®À» °­È­ÇÏ°í ¼­ºñ½º Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. ÇâÈÄ ¼ºÀåÀÇ ±æÀº °³ÀÎÈ­µÈ ÀÇ·á¿Í ´õ ³ªÀº Àç°í °ü¸® ¹× ȯÀÚ °á°ú¸¦ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À» ÃËÁøÇÏ´Â ±â¼ú µîÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ´ÜÀ§ ¿ë·® Á¦Á¶ »ê¾÷¿¡¼­ ÀÚº»À» È®º¸ÇϰíÀÚ ÇÏ´Â ±â¾÷µéÀº »õ·Î¿î »ê¾÷ Æ®·»µå¿¡ ¸ÂÃç Á¦Ç°À» Á¦°øÇϰí, ±ÔÁ¦¿¡ ´ëÇÑ ¹Îø¼º¿¡ ÃÊÁ¡À» ¸ÂÃß°í, ¾÷°è Ç¥Áذú ¼ÒºñÀÚ ±â´ëÄ¡¸¦ ¸ðµÎ ÃæÁ·ÇÏ´Â Áö¼Ó°¡´ÉÇÑ Æ÷Àå ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 233¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 276¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 778¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 18.76%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • Åõ¾à ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ ´ÜÀ§ ¿ë·® äÅà Áõ°¡
    • ÀçÆ÷À庸´Ù ´ÜÀ§ ¿ë·® »ý»êÀÌ ´õ ³´´Ù´Â ÀνÄÀÌ È®»êµÇ°í ÀÖ½À´Ï´Ù.
    • Á¦¾à »ê¾÷ÀÇ ±Þ¼ÓÇÑ ¹ßÀü
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¿øÀÚÀç °¡°Ý º¯µ¿
  • ½ÃÀå ±âȸ
    • Çõ½ÅÀûÀÎ Æ÷Àå ±â¼ú ¹× ¹è¼Û ¼Ö·ç¼Ç
    • °íü Á¦Á¦ ¿¬¼Ó »ý»ê(CM) äÅÃ
  • ½ÃÀå °úÁ¦
    • »ý»ê ´ÜÀ§ ¿ë·® äÅÿ¡ µû¸¥ ¹®Á¦

Porter's Five Forces : ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

"Porter's Five Forces" ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå : Á¦Ç°º°

  • ¾×ü ´ÜÀ§ ¿ë·®
  • °íÇü ´ÜÀ§ ¿ë·®

Á¦7Àå ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå Á¶´Þº°

  • »ç³»
  • ¾Æ¿ô¼Ò½Ì

Á¦8Àå ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • µ¶¸³ ¾à±¹
  • Àå±â°£º´ ½Ã¼³

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ´ÜÀ§ ¿ë·® Á¦Á¶ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Amcor PLC
  • American Health Packaging
  • Catalent Inc.
  • Cencora, Inc.
  • Corden Pharma GmbH
  • Medical Packaging Inc., LLC
  • Mikart, LLC
  • Patheon by Thermo Fisher Scientific Inc.
  • The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • Unither Pharmaceuticals SAS
ksm 24.11.29

The Unit Dose Manufacturing Market was valued at USD 23.34 billion in 2023, expected to reach USD 27.61 billion in 2024, and is projected to grow at a CAGR of 18.76%, to USD 77.81 billion by 2030.

Unit Dose Manufacturing involves the production of pre-measured, individualized doses of medications and is a vital component within the healthcare and pharmaceutical industries. Its necessity is emphasized by the growing demand for effective medication management, patient safety, and adherence to prescribed therapies, especially in hospitals and long-term care facilities. Applications extend beyond pharmaceuticals into nutraceuticals and over-the-counter medications, leveraging unit doses for precision and safety. End-use sectors include hospitals, home healthcare, and pharmacies. Key factors influencing market growth include increasing chronic disease prevalence, regulatory compliance for medication distribution, and the push for reduced medication errors. The growing trend of home healthcare services and the advancement of automated unit dose packaging technologies present potential opportunities for the market. Notably, technological innovations in smart packaging and automated dispensing systems are areas ripe for investment. However, the market faces limitations such as high initial implementation costs and a complex regulatory landscape that demands rigorous adherence. Moreover, the integration of advanced technologies requires skilled personnel, which can be a challenging factor given the workforce gap in specialized healthcare domains. Innovation and research should focus on developing cost-effective, efficient packaging solutions and integrating digital health technologies that enhance tracking and monitoring of medication adherence. The market's nature is competitive, with companies vying to enhance their technological capabilities and expand their service portfolios. Future growth avenues may include personalized medicine and technologies that facilitate real-time data analytics for better inventory management and patient outcomes. For companies aiming to capitalize on the unit dose manufacturing industry, it is critical to align product offerings with emerging industry trends, focus on regulatory agility, and invest in sustainable packaging solutions that meet both industry standards and consumer expectations.

KEY MARKET STATISTICS
Base Year [2023] USD 23.34 billion
Estimated Year [2024] USD 27.61 billion
Forecast Year [2030] USD 77.81 billion
CAGR (%) 18.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Unit Dose Manufacturing Market

The Unit Dose Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of unit doses to reduce medication errors
    • Rising awareness of benefits of manufacturing unit doses over repackaging
    • Rapid development in the pharmaceutical industry
  • Market Restraints
    • Fluctuations in the prices of raw materials
  • Market Opportunities
    • Innovative packaging technologies and delivery solutions
    • Adopting continuous manufacturing (CM) for solid-dose drug products
  • Market Challenges
    • Issues associated with the adoption of manufactured unit doses

Porter's Five Forces: A Strategic Tool for Navigating the Unit Dose Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Unit Dose Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Unit Dose Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Unit Dose Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Unit Dose Manufacturing Market

A detailed market share analysis in the Unit Dose Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Unit Dose Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Unit Dose Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Unit Dose Manufacturing Market

A strategic analysis of the Unit Dose Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Unit Dose Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, American Health Packaging, Catalent Inc., Cencora, Inc., Corden Pharma GmbH, Medical Packaging Inc., LLC, Mikart, LLC, Patheon by Thermo Fisher Scientific Inc., The Tapemark Company by LTS Lohmann Therapie-Systeme AG, and Unither Pharmaceuticals SAS.

Market Segmentation & Coverage

This research report categorizes the Unit Dose Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose.
  • Based on Sourcing, market is studied across In-House and Outsourcing.
  • Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
      • 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
      • 5.1.1.3. Rapid development in the pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in the prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative packaging technologies and delivery solutions
      • 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the adoption of manufactured unit doses
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Unit Dose Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Unit Dose
  • 6.3. Solid Unit Dose

7. Unit Dose Manufacturing Market, by Sourcing

  • 7.1. Introduction
  • 7.2. In-House
  • 7.3. Outsourcing

8. Unit Dose Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Pharmacies
  • 8.4. Long Term Care Facility

9. Americas Unit Dose Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Unit Dose Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Unit Dose Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor PLC
  • 2. American Health Packaging
  • 3. Catalent Inc.
  • 4. Cencora, Inc.
  • 5. Corden Pharma GmbH
  • 6. Medical Packaging Inc., LLC
  • 7. Mikart, LLC
  • 8. Patheon by Thermo Fisher Scientific Inc.
  • 9. The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • 10. Unither Pharmaceuticals SAS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦